Search

Your search keyword '"Morisco, Filomena"' showing total 949 results

Search Constraints

Start Over You searched for: Author "Morisco, Filomena" Remove constraint Author: "Morisco, Filomena" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
949 results on '"Morisco, Filomena"'

Search Results

1. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study

2. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

3. Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline

4. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

5. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept

6. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

7. THU-378 Prediction of outcomes in patients with HCV compensated liver cirrhosis after SVR: results from 5-years of follow-up

8. SAT-007-YI Assessing sex differences in access to liver transplantation in Italy: a real-world nationwide study

9. FRI-078-YI Long-term albumin administration in outpatients with decompensated cirrhosis and diabetes mellitus: post-hoc analysis of the ANSWER trial database

10. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort

11. WED-414 Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)

12. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid

13. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

14. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients

16. Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study.

17. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

18. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort

21. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.

22. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

23. Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.

24. Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome.

28. HepaDisk – A new quality of life questionnaire for HCV patients

32. Anti‐HDV reflex testing in HBsAg‐positive subjects: An efficacious strategy to identify HDV infection

33. Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis

35. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

36. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

37. Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage

38. COVID-19 and Fatty Liver Disorders

41. Implementation of anti-HDV reflex testing among HBsAg-positive in a tertiary center in South Italy

42. Predicting de‐novoportal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort

44. HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study

45. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

47. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology

49. Anti‐HDV reflex testing in HBsAg‐positive subjects: An efficacious strategy to identify HDV infection.

Catalog

Books, media, physical & digital resources